Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Reversal Under Sevoflurane vs Desflurane in Children
NCT03795259Completed
- Sponsor
- Istanbul University
- Start
- Dec 2018
- Primary completion
- May 2019
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Istanbul University. Primary endpoints: Time from TOF of 25% to 90% after sugammadex injection, Time from TOF of 100% to 0% after rocuronium injection and 2 more. Started Dec 2018; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03795259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03795259.